Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 289 to 300 of 300 entries
Sorted by: Best Match Show Resources per page
Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display.

bioRxiv : the preprint server for biology

Tanaka S, Anders Olson C, Barnes CO, Higashide W, Gonzalez M, Taft J, Richardson A, Martin-Fernandez M, Bogunovic D, Gnanapragasam PNP, Bjorkman PJ, Spilman P, Niazi K, Rabizadeh S, Soon-Shiong P.
PMID: 34545362
bioRxiv. 2021 Sep 14; doi: 10.1101/2021.09.14.460356.

The increasing prevalence of SARS-CoV-2 variants with the ability to escape existing humoral protection conferred by previous infection and/or immunization necessitates the discovery of broadly-reactive neutralizing antibodies (nAbs). Utilizing mRNA display, we identified a set of antibodies against SARS-CoV-2...

Cite
Tanaka S, Anders Olson C, Barnes CO, et al. Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display. bioRxiv. 2021;doi: 10.1101/2021.09.14.460356.
Tanaka, S., Anders Olson, C., Barnes, C. O., Higashide, W., Gonzalez, M., Taft, J., Richardson, A., Martin-Fernandez, M., Bogunovic, D., Gnanapragasam, P. N. P., Bjorkman, P. J., Spilman, P., Niazi, K., Rabizadeh, S., & Soon-Shiong, P. (2021). Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.09.14.460356
Tanaka, Shiho, et al. "Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.09.14.460356
Tanaka S, Anders Olson C, Barnes CO, Higashide W, Gonzalez M, Taft J, Richardson A, Martin-Fernandez M, Bogunovic D, Gnanapragasam PNP, Bjorkman PJ, Spilman P, Niazi K, Rabizadeh S, Soon-Shiong P. Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display. bioRxiv. 2021 Sep 14; doi: 10.1101/2021.09.14.460356. PMID: 34545362; PMCID: PMC8452091.
Copy Download .nbib Format: NLM
Paraganglioma of the filum terminal: Case report and review of the literature.

International journal of surgery case reports

Rahimizadeh A, Ahmadi SA, Koshki AM, Rahimizadeh A, Karimi M.
PMID: 33360629
Int J Surg Case Rep. 2021 Jan;78:103-109. doi: 10.1016/j.ijscr.2020.11.038. Epub 2020 Nov 11.

Paraganglioma of the filum terminal/cauda equina is a rare slow growing tumor which originates from the ectopic sympathetic neurons. Surgically, total excision may be difficult for this well demarcated tumor surrounded by couple of rootlets but is usually possible...

Cite
Rahimizadeh A, Ahmadi SA, Koshki AM, et al. Paraganglioma of the filum terminal: Case report and review of the literature. Int J Surg Case Rep. 2020;78:103-109doi: 10.1016/j.ijscr.2020.11.038.
Rahimizadeh, A., Ahmadi, S. A., Koshki, A. M., Rahimizadeh, A., & Karimi, M. (2021). Paraganglioma of the filum terminal: Case report and review of the literature. International journal of surgery case reports, 78103-109. https://doi.org/10.1016/j.ijscr.2020.11.038
Rahimizadeh, Abolfazl, et al. "Paraganglioma of the filum terminal: Case report and review of the literature." International journal of surgery case reports vol. 78 (2021): 103-109. doi: https://doi.org/10.1016/j.ijscr.2020.11.038
Rahimizadeh A, Ahmadi SA, Koshki AM, Rahimizadeh A, Karimi M. Paraganglioma of the filum terminal: Case report and review of the literature. Int J Surg Case Rep. 2021 Jan;78:103-109. doi: 10.1016/j.ijscr.2020.11.038. Epub 2020 Nov 11. PMID: 33360629; PMCID: PMC7773680.
Copy Download .nbib Format: NLM
Novel Strategies to Combat Bacterial Biofilms.

Molecular biotechnology

Hemmati F, Rezaee MA, Ebrahimzadeh S, Yousefi L, Nouri R, Kafil HS, Gholizadeh P.
PMID: 33914260
Mol Biotechnol. 2021 Jul;63(7):569-586. doi: 10.1007/s12033-021-00325-8. Epub 2021 Apr 29.

Biofilms are considered as a severe problem in the treatment of bacterial infections; their development causes some noticeable resistance to antibacterial agents. Biofilms are responsible for at least two-thirds of all infections, displaying promoted resistance to classical antibiotic treatments....

Cite
Hemmati F, Rezaee MA, Ebrahimzadeh S, et al. Novel Strategies to Combat Bacterial Biofilms. Mol Biotechnol. 2021;63(7):569-586doi: 10.1007/s12033-021-00325-8.
Hemmati, F., Rezaee, M. A., Ebrahimzadeh, S., Yousefi, L., Nouri, R., Kafil, H. S., & Gholizadeh, P. (2021). Novel Strategies to Combat Bacterial Biofilms. Molecular biotechnology, 63(7), 569-586. https://doi.org/10.1007/s12033-021-00325-8
Hemmati, Fatemeh, et al. "Novel Strategies to Combat Bacterial Biofilms." Molecular biotechnology vol. 63,7 (2021): 569-586. doi: https://doi.org/10.1007/s12033-021-00325-8
Hemmati F, Rezaee MA, Ebrahimzadeh S, Yousefi L, Nouri R, Kafil HS, Gholizadeh P. Novel Strategies to Combat Bacterial Biofilms. Mol Biotechnol. 2021 Jul;63(7):569-586. doi: 10.1007/s12033-021-00325-8. Epub 2021 Apr 29. PMID: 33914260.
Copy Download .nbib Format: NLM
Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.

Virology

Naderi N, Rahimzadeh M.
PMID: 34896901
Virology. 2021 Dec 04;566:106-113. doi: 10.1016/j.virol.2021.11.006. Epub 2021 Dec 04.

BACKGROUND: Krebs von den Lungen-6 (KL-6) is a molecule that is predominantly expressed by damaged alveolar type II cells, and has been proposed as a marker of COVID-19 and the severity of the disease. Here, we performed a meta-analysis...

Cite
Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology. 2021;566:106-113doi: 10.1016/j.virol.2021.11.006.
Naderi, N., & Rahimzadeh, M. (2021). Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology, 566106-113. https://doi.org/10.1016/j.virol.2021.11.006
Naderi, Nadereh, and Rahimzadeh, Mahsa. "Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses." Virology vol. 566 (2021): 106-113. doi: https://doi.org/10.1016/j.virol.2021.11.006
Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology. 2021 Dec 04;566:106-113. doi: 10.1016/j.virol.2021.11.006. Epub 2021 Dec 04. PMID: 34896901; PMCID: PMC8642780.
Copy Download .nbib Format: NLM
Comparison of the effect of insulin glargine and regular insulin on perioperative glycemic control in patients with type 2 diabetes mellitus under insulin treatment during vitrectomy surgery under general anesthesia: A randomized clinical trial study.

Medical journal of the Islamic Republic of Iran

Derakhshan P, Khatibi A, Faiz SHR, Rahimzadeh P, Nouri N.
PMID: 34211933
Med J Islam Repub Iran. 2021 Mar 06;35:31. doi: 10.47176/mjiri.35.31. eCollection 2021.

No abstract available.

Cite
Derakhshan P, Khatibi A, Faiz SHR, et al. Comparison of the effect of insulin glargine and regular insulin on perioperative glycemic control in patients with type 2 diabetes mellitus under insulin treatment during vitrectomy surgery under general anesthesia: A randomized clinical trial study. Med J Islam Repub Iran. 2021;35:31doi: 10.47176/mjiri.35.31.
Derakhshan, P., Khatibi, A., Faiz, S. H. R., Rahimzadeh, P., & Nouri, N. (2021). Comparison of the effect of insulin glargine and regular insulin on perioperative glycemic control in patients with type 2 diabetes mellitus under insulin treatment during vitrectomy surgery under general anesthesia: A randomized clinical trial study. Medical journal of the Islamic Republic of Iran, 3531. https://doi.org/10.47176/mjiri.35.31
Derakhshan, Pooya, et al. "Comparison of the effect of insulin glargine and regular insulin on perioperative glycemic control in patients with type 2 diabetes mellitus under insulin treatment during vitrectomy surgery under general anesthesia: A randomized clinical trial study." Medical journal of the Islamic Republic of Iran vol. 35 (2021): 31. doi: https://doi.org/10.47176/mjiri.35.31
Derakhshan P, Khatibi A, Faiz SHR, Rahimzadeh P, Nouri N. Comparison of the effect of insulin glargine and regular insulin on perioperative glycemic control in patients with type 2 diabetes mellitus under insulin treatment during vitrectomy surgery under general anesthesia: A randomized clinical trial study. Med J Islam Repub Iran. 2021 Mar 06;35:31. doi: 10.47176/mjiri.35.31. eCollection 2021. PMID: 34211933; PMCID: PMC8236081.
Copy Download .nbib Format: NLM
Treatment for vestibular schwannoma: Systematic review and single arm meta-analysis.

American journal of otolaryngology

Thai NLB, Mai NY, Vuong NL, Tin NM, Karam D, Refaey MA, Shahin KM, Soliman AL, Al Khudari R, Thuan TM, Sabbah GM, El-Qushayri AE, Karimzadeh S, Hirayama K, Huy NT.
PMID: 34973662
Am J Otolaryngol. 2021 Dec 20;43(2):103337. doi: 10.1016/j.amjoto.2021.103337. Epub 2021 Dec 20.

OBJECTIVE: Vestibular schwannoma is a benign tumor in the schwannoma cells of the 8th cranial nerve. It causes symptoms like tinnitus, vertigo and end up with loss of hearing so the appropriate treatment is very important. There are many...

Cite
Thai NLB, Mai NY, Vuong NL, et al. Treatment for vestibular schwannoma: Systematic review and single arm meta-analysis. Am J Otolaryngol. 2021;43(2):103337doi: 10.1016/j.amjoto.2021.103337.
Thai, N. L. B., Mai, N. Y., Vuong, N. L., Tin, N. M., Karam, D., Refaey, M. A., Shahin, K. M., Soliman, A. L., Al Khudari, R., Thuan, T. M., Sabbah, G. M., El-Qushayri, A. E., Karimzadeh, S., Hirayama, K., & Huy, N. T. (2021). Treatment for vestibular schwannoma: Systematic review and single arm meta-analysis. American journal of otolaryngology, 43(2), 103337. https://doi.org/10.1016/j.amjoto.2021.103337
Thai, Nghia Le Ba, et al. "Treatment for vestibular schwannoma: Systematic review and single arm meta-analysis." American journal of otolaryngology vol. 43,2 (2021): 103337. doi: https://doi.org/10.1016/j.amjoto.2021.103337
Thai NLB, Mai NY, Vuong NL, Tin NM, Karam D, Refaey MA, Shahin KM, Soliman AL, Al Khudari R, Thuan TM, Sabbah GM, El-Qushayri AE, Karimzadeh S, Hirayama K, Huy NT. Treatment for vestibular schwannoma: Systematic review and single arm meta-analysis. Am J Otolaryngol. 2021 Dec 20;43(2):103337. doi: 10.1016/j.amjoto.2021.103337. Epub 2021 Dec 20. PMID: 34973662.
Copy Download .nbib Format: NLM
The concentration and health risk assessment of radionuclides in the muscle of tuna fish: A worldwide systematic review and meta-analysis.

Chemosphere

Fakhri Y, Sarafraz M, Pilevar Z, Daraei H, Rahimizadeh A, Kazemi S, Khedher KM, Thai VN, Ba LH, Mousavi Khaneghah A.
PMID: 34871618
Chemosphere. 2021 Dec 03;289:133149. doi: 10.1016/j.chemosphere.2021.133149. Epub 2021 Dec 03.

Exposure to radionuclides, especially in food, can endanger the health of consumers. In this study, a systematic review and meta-analysis were performed regarding the concentration of radionuclides in tuna fish muscle. International databases including PubMed, Scopus, and Embase were...

Cite
Fakhri Y, Sarafraz M, Pilevar Z, et al. The concentration and health risk assessment of radionuclides in the muscle of tuna fish: A worldwide systematic review and meta-analysis. Chemosphere. 2021;289:133149doi: 10.1016/j.chemosphere.2021.133149.
Fakhri, Y., Sarafraz, M., Pilevar, Z., Daraei, H., Rahimizadeh, A., Kazemi, S., Khedher, K. M., Thai, V. N., Ba, L. H., & Mousavi Khaneghah, A. (2021). The concentration and health risk assessment of radionuclides in the muscle of tuna fish: A worldwide systematic review and meta-analysis. Chemosphere, 289133149. https://doi.org/10.1016/j.chemosphere.2021.133149
Fakhri, Yadolah, et al. "The concentration and health risk assessment of radionuclides in the muscle of tuna fish: A worldwide systematic review and meta-analysis." Chemosphere vol. 289 (2021): 133149. doi: https://doi.org/10.1016/j.chemosphere.2021.133149
Fakhri Y, Sarafraz M, Pilevar Z, Daraei H, Rahimizadeh A, Kazemi S, Khedher KM, Thai VN, Ba LH, Mousavi Khaneghah A. The concentration and health risk assessment of radionuclides in the muscle of tuna fish: A worldwide systematic review and meta-analysis. Chemosphere. 2021 Dec 03;289:133149. doi: 10.1016/j.chemosphere.2021.133149. Epub 2021 Dec 03. PMID: 34871618.
Copy Download .nbib Format: NLM
Evaluation of Anti-oxidant and Anti-biofilm Activities of Biogenic Surfactants Derived from .

Iranian journal of pharmaceutical research : IJPR

Abdollahi S, Tofighi Z, Babaee T, Shamsi M, Rahimzadeh G, Rezvanifar H, Saeidi E, Mohajeri Amiri M, Saffari Ashtiani Y, Samadi N.
PMID: 33224216
Iran J Pharm Res. 2020;19(2):115-126. doi: 10.22037/IJPR.2020.1101033.

Biosurfactants, the microbial originated surface active agents, can modify the physicochemical properties of surfaces and reduce the bacterial adhesion via changing bacterial adhesion interactions on surfaces. They were also able to block oxidative chain reactions and might show antioxidant...

Cite
Abdollahi S, Tofighi Z, Babaee T, et al. Evaluation of Anti-oxidant and Anti-biofilm Activities of Biogenic Surfactants Derived from . Iran J Pharm Res. 2020;19(2):115-126doi: 10.22037/IJPR.2020.1101033.
Abdollahi, S., Tofighi, Z., Babaee, T., Shamsi, M., Rahimzadeh, G., Rezvanifar, H., Saeidi, E., Mohajeri Amiri, M., Saffari Ashtiani, Y., & Samadi, N. (2020). Evaluation of Anti-oxidant and Anti-biofilm Activities of Biogenic Surfactants Derived from . Iranian journal of pharmaceutical research : IJPR, 19(2), 115-126. https://doi.org/10.22037/IJPR.2020.1101033
Abdollahi, Soosan, et al. "Evaluation of Anti-oxidant and Anti-biofilm Activities of Biogenic Surfactants Derived from ." Iranian journal of pharmaceutical research : IJPR vol. 19,2 (2020): 115-126. doi: https://doi.org/10.22037/IJPR.2020.1101033
Abdollahi S, Tofighi Z, Babaee T, Shamsi M, Rahimzadeh G, Rezvanifar H, Saeidi E, Mohajeri Amiri M, Saffari Ashtiani Y, Samadi N. Evaluation of Anti-oxidant and Anti-biofilm Activities of Biogenic Surfactants Derived from . Iran J Pharm Res. 2020;19(2):115-126. doi: 10.22037/IJPR.2020.1101033. PMID: 33224216; PMCID: PMC7667535.
Copy Download .nbib Format: NLM
Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.

Virology

Naderi N, Rahimzadeh M.
PMID: 34896901
Virology. 2021 Dec 04;566:106-113. doi: 10.1016/j.virol.2021.11.006. Epub 2021 Dec 04.

BACKGROUND: Krebs von den Lungen-6 (KL-6) is a molecule that is predominantly expressed by damaged alveolar type II cells, and has been proposed as a marker of COVID-19 and the severity of the disease. Here, we performed a meta-analysis...

Cite
Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology. 2021;566:106-113doi: 10.1016/j.virol.2021.11.006.
Naderi, N., & Rahimzadeh, M. (2021). Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology, 566106-113. https://doi.org/10.1016/j.virol.2021.11.006
Naderi, Nadereh, and Rahimzadeh, Mahsa. "Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses." Virology vol. 566 (2021): 106-113. doi: https://doi.org/10.1016/j.virol.2021.11.006
Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology. 2021 Dec 04;566:106-113. doi: 10.1016/j.virol.2021.11.006. Epub 2021 Dec 04. PMID: 34896901.
Copy Download .nbib Format: NLM
Hybrid Percutaneous Brachiofemoral Shunt and Open Abdominal Aortic Aneurysm Repair in a Kidney Transplant Recipient.

Case reports in vascular medicine

Salimi J, Sadat SA, Yavari Barhaghtalab MJ, Rahimzadeh H.
PMID: 34381624
Case Rep Vasc Med. 2021 Jul 31;2021:6655660. doi: 10.1155/2021/6655660. eCollection 2021.

Abdominal aortic aneurysm (AAA) repair in kidney transplant recipients may cause ischemia in the transplanted kidney. As a result, various techniques have been described for protection of the renal allograft during AAA repair including temporary shunt, extracorporeal bypass, cold...

Cite
Salimi J, Sadat SA, Yavari Barhaghtalab MJ, et al. Hybrid Percutaneous Brachiofemoral Shunt and Open Abdominal Aortic Aneurysm Repair in a Kidney Transplant Recipient. Case Rep Vasc Med. 2021;2021:6655660doi: 10.1155/2021/6655660.
Salimi, J., Sadat, S. A., Yavari Barhaghtalab, M. J., & Rahimzadeh, H. (2021). Hybrid Percutaneous Brachiofemoral Shunt and Open Abdominal Aortic Aneurysm Repair in a Kidney Transplant Recipient. Case reports in vascular medicine, 20216655660. https://doi.org/10.1155/2021/6655660
Salimi, Javad, et al. "Hybrid Percutaneous Brachiofemoral Shunt and Open Abdominal Aortic Aneurysm Repair in a Kidney Transplant Recipient." Case reports in vascular medicine vol. 2021 (2021): 6655660. doi: https://doi.org/10.1155/2021/6655660
Salimi J, Sadat SA, Yavari Barhaghtalab MJ, Rahimzadeh H. Hybrid Percutaneous Brachiofemoral Shunt and Open Abdominal Aortic Aneurysm Repair in a Kidney Transplant Recipient. Case Rep Vasc Med. 2021 Jul 31;2021:6655660. doi: 10.1155/2021/6655660. eCollection 2021. PMID: 34381624; PMCID: PMC8352712.
Copy Download .nbib Format: NLM
Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.

Virology

Naderi N, Rahimzadeh M.
PMID: 34896901
Virology. 2021 Dec 04;566:106-113. doi: 10.1016/j.virol.2021.11.006. Epub 2021 Dec 04.

BACKGROUND: Krebs von den Lungen-6 (KL-6) is a molecule that is predominantly expressed by damaged alveolar type II cells, and has been proposed as a marker of COVID-19 and the severity of the disease. Here, we performed a meta-analysis...

Cite
Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology. 2021;566:106-113doi: 10.1016/j.virol.2021.11.006.
Naderi, N., & Rahimzadeh, M. (2021). Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology, 566106-113. https://doi.org/10.1016/j.virol.2021.11.006
Naderi, Nadereh, and Rahimzadeh, Mahsa. "Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses." Virology vol. 566 (2021): 106-113. doi: https://doi.org/10.1016/j.virol.2021.11.006
Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology. 2021 Dec 04;566:106-113. doi: 10.1016/j.virol.2021.11.006. Epub 2021 Dec 04. PMID: 34896901.
Copy Download .nbib Format: NLM
Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.

Virology

Naderi N, Rahimzadeh M.
PMID: 34896901
Virology. 2021 Dec 04;566:106-113. doi: 10.1016/j.virol.2021.11.006. Epub 2021 Dec 04.

BACKGROUND: Krebs von den Lungen-6 (KL-6) is a molecule that is predominantly expressed by damaged alveolar type II cells, and has been proposed as a marker of COVID-19 and the severity of the disease. Here, we performed a meta-analysis...

Cite
Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology. 2021;566:106-113doi: 10.1016/j.virol.2021.11.006.
Naderi, N., & Rahimzadeh, M. (2021). Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology, 566106-113. https://doi.org/10.1016/j.virol.2021.11.006
Naderi, Nadereh, and Rahimzadeh, Mahsa. "Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses." Virology vol. 566 (2021): 106-113. doi: https://doi.org/10.1016/j.virol.2021.11.006
Naderi N, Rahimzadeh M. Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses. Virology. 2021 Dec 04;566:106-113. doi: 10.1016/j.virol.2021.11.006. Epub 2021 Dec 04. PMID: 34896901.
Copy Download .nbib Format: NLM
Showing 289 to 300 of 300 entries